Gert Riethmüller mostly deals with Pathology, Antigen, Bone marrow, Monoclonal antibody and Molecular biology. Gert Riethmüller has researched Pathology in several fields, including Cancer, Primary tumor and Complement system. His work carried out in the field of Antigen brings together such families of science as Antibody and Virology.
His Bone marrow research integrates issues from Metastasis and Micrometastasis. The concepts of his Monoclonal antibody study are interwoven with issues in Immunohistochemistry, Staining and Melanoma. He interconnects Cell culture, Genetics, Nucleic acid sequence, Peptide sequence and Cytotoxic T cell in the investigation of issues within Molecular biology.
His primary areas of investigation include Molecular biology, Monoclonal antibody, Antibody, Antigen and Immunology. His Molecular biology research incorporates themes from Cell culture, Peripheral blood mononuclear cell, Monocyte, Epitope and Cytotoxic T cell. His research integrates issues of Immunofluorescence and Glycoprotein in his study of Monoclonal antibody.
The various areas that Gert Riethmüller examines in his Antibody study include Spleen, In vitro and Immunotherapy. His Antigen research incorporates elements of Receptor, Virology, Melanoma and Pathology. His study explores the link between Pathology and topics such as Metastasis that cross with problems in Bone marrow.
His primary areas of study are Cancer research, Antibody, Immunology, Bone marrow and Pathology. His Antibody study combines topics from a wide range of disciplines, such as Immune system, Immunotherapy and Antigen. His Antigen research incorporates elements of Titer and Cytotoxic T cell.
His Immunology research is multidisciplinary, incorporating perspectives in Targeted therapy and In vivo. His Pathology research incorporates themes from Survival analysis, Breast cancer and Metastasis. His biological study spans a wide range of topics, including Epitope, Molecular biology, Antibody titer and Immunoglobulin G.
Gert Riethmüller mainly focuses on Immunology, Cancer research, T cell, Metastasis and Pathology. His work deals with themes such as Antibody, MHC class I and Cytotoxicity, which intersect with T cell. His Antibody study frequently draws parallels with other fields, such as Antigen.
His Antigen research is multidisciplinary, relying on both Targeted therapy and Chemotherapy. His research in Metastasis intersects with topics in Neoplasm, Bone marrow and Genotype. His Pathology study frequently draws connections to other fields, such as Genetic heterogeneity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Stephan Braun;Klaus Pantel;Peter Müller;Wolfgang Janni.
The New England Journal of Medicine (2000)
Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Max S. Topp;Peter Kufer;Nicola Gökbuget;Mariele Goebeler.
Journal of Clinical Oncology (2011)
Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes
H. W. Löms Ziegler-Heitbroc;Eckhard Thiel;Agnes Futterer;Volker Herzog.
International Journal of Cancer (1988)
Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.
Gerald Messer;Ulrich Spengler;Maria C. Jung;G. Honold.
Journal of Experimental Medicine (1991)
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
G Riethmüller;E Holz;G Schlimok;W Schmiegel.
Journal of Clinical Oncology (1998)
Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
Christoph A. Klein;Oleg Schmidt-Kittler;Julian A. Schardt;Klaus Pantel.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells
Klaus Pantel;Günter Schlimok;Stephan Braun;Dominik Kutter.
Journal of the National Cancer Institute (1993)
Capillary deposition of C4d complement fragment and early renal graft loss
Helmut E. Feucht;Helmut Schneeberger;Günther Hillebrand;Klaus Burkhardt.
Kidney International (1993)
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
Christoph A Klein;Thomas J F Blankenstein;Oleg Schmidt-Kittler;Marco Petronio.
The Lancet (2002)
A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity
Matthias Mack;Gert Riethmuller;Peter Kufer.
Proceedings of the National Academy of Sciences of the United States of America (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: